Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
20 YEARS OFGENOMICS
Past and futuredirections
March 28, 2019
PARIS, France
PROGRAM
INVITATION TO THE 20 YEARS OF GENOMICS: past and future directions
Dear Colleagues, dear Friends,
Twenty years ago, our genomics core facility has been established from a partnership
between the Institut Curie, the École Supérieure de Physique et Chimie Industrielles de la
ville de Paris (ESPCI) and the École normale supérieure (ENS). Since its inception, we
focused our activity on functional genomics analysis of eukaryotes to help laboratories
design and conduct state of the art high-throughput projects from the experimental
design to data analysis. We have been key players on many fields including yeast
sequencing genome project, microarrays development, single cell gene expression, high
throughput sequencing revolution and now nanopore technologies.
In order to celebrate this anniversary, we will organize in Paris on March the 28th 2019 a
half-day meeting entitled: “20 years of genomics past and future directions”. This event
will feature a series of talks covering key research fields in genomics. We will look at the
past of course, but we will also discuss the future of the field. The afternoon will be
followed by a reception at the Musée d’Orsay including a gala dinner and a guided tour of
the remarkable art collections.
The conference will be held at the École normale supérieure in Paris, with an exceptional
speaker line up including Clive Brown, Ana Conesa Cegarra, Denis Milan and CatherineNguyen. It will also be the occasion to meet biotech companies involved in future
applications for genomics.
Follow us on Twitter #20yearsofgenomics and LinkedIn
We are looking forward to that celebration where we expect great exchanges on past and
future challenges in genomics.
Stéphane LE CROM,
Scientific head of genomics core facility
PROGRAM | 2
TIME
13H-13H30 Welcome coffee and registration
13H30-13H40 Introduction
13H40-14H30
14H30-15H20 Catherine Nguyen, Inserm - Health genomics
15H20-16H10 Coffee break and meetings with biotech involved in genomics challenges
16H10-17H00
17H00-17H50 Ana Conesa Cegarra, Príncipe Felipe Research Center - Bioinformatics and transcriptomics
17H50-18H00 Closing remarks
19H-20H30 Orsay Museum guided visit
20H30 Anniversary gala dinner at the Orsay Museum
SESSIONS & SPEAKERS
PROGRAM OF THE CONFERENCE
PROGRAM | 3
Clive G Brown, Oxford Nanopore Technologies - Sequencing
Denis Milan, INRA - Agrogenomics
SPEAKERS
Clive BrownChief Technology Officer
Oxford Nanopore Technologies
Oxford – United Kingdom
20 years of sequencing
Clive is Chief Technology Officer at Oxford Nanopore. On the Executive team, he is
responsible for all of the Company’s product-development activities. Clive leads the
specification and design of the Company’s nanopore-based sensing platform, including
strand DNA/RNA sequencing and protein-sensing applications with a strong focus on
scientific excellence and successful adoption by the scientific community.
Clive joined Oxford Nanopore from the Wellcome Trust Sanger Institute (Cambridge, UK)
where he played a key role in the adoption and exploitation of 'next generation' DNA
sequencing platforms. This involved helping to set up the world’s largest single installation
of Illumina (formerly Solexa) Genome Analyzers in a production sequencing environment,
initially used to pioneer the 1000 genomes project.
From early 2003 he was Director of Computational Biology and IT at Solexa Ltd, where he
was central to the development and commercialisation of the Genome Analyzer (GA).
Solexa was sold to Illumina for $650m in early 2007 after the successful placement and
adoption of 12 instruments. The Solexa technology, now commercialised by Illumina, is the
market-leading DNA sequencing technology driving the renaissance in DNA-based
discovery.
He has a strong background in computer science and genetics/molecular biology and
manages interdisciplinary teams including mechanical engineering, electronics, physics,
surface chemistry, electrophysiology, software engineering and applications (of the
technology). Clive applies modern agile management techniques to the entire product-
development lifecycle.
Clive has also held various management and consulting positions at GlaxoWellcome,
Oxford Glycosciences and other EU- and US-based organisations. He has worked at the
interface between computing and science, ranging from genetics to proteomics. He holds
degrees in Genetics and Computational Biology from the University of York.
PROGRAM | 4
SPEAKERS
Ana ConesaProfessor of Bioinformatics
University of Florida
Gainesville – United States of America
Multi-omics and third generation sequencing strategies for the future ofgenome research
Ana Conesa is Professor of Bioinformatics at the Microbiology and Cell Science
Department at the University of and founder of the Bioinformatics company Biobam SL.
She graduated as Agricultural Engineer at the Polytechnical University of Valencia in 1993
and did her PhD in at the University of Leiden in the Netherlands. After a short
appointment as bioinformatics project leader at TNO Quality of Life (The Netherlands) she
obtained a Ramon y Cajal award and joined the Valencia Agricultural Research Institute in
2003. She moved to the Prince Felipe Research Center in 2007. She became UF Professor
in 2014.
Ana Conesa’s group is interested in understanding functional aspects of gene expression
at the genome-wide level and across different organisms. Her has developed statistical
methods and software tools that analyze the dynamics aspects transcriptomes, integrate
these with other types of molecular data and annotate them functionally, with a special
focus on Next Generation Sequencing (NGS) data. Some of our popular software tools are
Blast2GO, PaintOmics, maSigPro, NOISeq, Qualimap, SQANTI, tapppAS, etc. She has lead
international projects such as STATegra and DEANN where European and American
scientists developed new tools for the analysis of sequencing data. She has published over
110 research papers that have received more than 17,000 citations.
PROGRAM | 5
Denis MilanDirector of Research
France Genomics infrastructure deputy director
INRA - French National Institute for Agricultural Research
Castanet-Tolosan – France
20 years of agrigenomics: past and future directions
Denis Milan is an agricultural engineer from the Institut National Agronomique Paris
Grignon. After a thesis in retrovirology at the Institut Pasteur, he joined INRA at the
Toulouse research centre.
His scientific work focused on the knowledge of the porcine genome with the
development of genetic and physical maps of the porcine genome and then the
sequencing of this genome within the framework of an international consortium. He has
also worked on the mapping of QTL and major genes in pigs, including the identification of
a mutation in a gene involved in meat quality, the first strict positional cloning in species of
agronomic interest. He served as Head of the Animal Genetics Division at INRA from 2010
to 2017. Over the period 2011-2018 he also headed the INRA metaprogram dedicated to
genomic selection in animal and plant species.
Since 2003 he has been director and then scientific director of the Genomics platform that
became GeT (Genome and Transcriptome) in 2010, bringing together several sites in
Toulouse. In 2008-2009 he chaired the INRA national commission dedicated to platforms.
He has participated in the setting up of the France Genomics infrastructure, of which he is
deputy director.
SPEAKERS
PROGRAM | 6
Catherine NGuyenDirector of Research
Genetics, genomics and bioinformatics Institute (Aviesan) director
Inserm - French National Institute of Health and Medical research
Marseille – France
The impact of the transcriptomic to the exploration of the living and inmedical genomics
Director of Research at INSERM, Catherine Nguyen first led the ERITM and the ERM 206
from 2002 to 2008, then took over the leadership of TAGC-UMR 1090 (Advanced
Technologies for Genome and Clinic) from its creation in 2008 until 2018 as well as the co-
management of its platform IBiSA TGML (Transcriptomics and Genomics-Marseille
Luminy). In 2016, she is appointed Director of the Thematic Institute Multi-Organisms
"Genetics, Genomics and Bioinformatics" where she works to structure these disciplines in
the research landscape, and more specifically at INSERM.
Since joining INSERM, she has been involved in the development of genomics approaches
that she has applied to her research in immunology and oncology. She co-authored more
than a hundred articles and reviews in international publications.
Throughout her career, she fervently work on promoting technological deployment in
genomics for the benefit of the scientific advancement. She is a pioneer of the
transcriptomic by not only actively contributing to the development of its concept but also
to the evolution of its application. In addition, in 1998, she actively participated in
structuring the development of bioinformatics.
Always focused on the transmission of knowledge and its validation, she has actively
participated in the development of research in these areas. She provided training and
logistical support to many projects, and contributed to the networking of the development
of transcriptomic platforms at national and international level. Beyond the fundamental
aspect, her work led to the definition of new tools for diagnosis and/or prognosis thus
helping practitioners.
She has always been an advocate for spreading know-how, providing training at national
and international level (Brazil, Thailand), and participating in the establishment of research
Masters, particularly in Lebanon and in Vietnam (USTH program).
SPEAKERS
PROGRAM | 7
Philippe MarcDirector of Research
Global Head of Integrated Data Sciences
Novartis Institutes for BioMedical Research (NIBR)
Basel - Switzerland
Philippe MARC obtained a Ph.D. in Computational Science from Paris Diderot University
before completing a systems biology-oriented postdoctoral fellowship in the lab of George
Church at Harvard Medical School. He then worked for Aventis and Sanofi before joining
Novartis a decade years ago. At Novartis, his team developed tools to improve and
expedite Translational Medicine data analysis and decision-making. He is also leading the
data standardization and visualization work of the Innovative Medicine Initiative eTOX
project.
SCIENTIFIC ORGANIZING COMMITTEE
Frédéric DevauxProfessor of genomics
Sorbonne Université, IBPS – Institut de Biologie Paris Seine
Paris – France
F. Devaux got his PhD in functional genomics in 2001 at Université Pierre et Marie Curie
(UPMC, Paris, France). He was recruited as an assistant professor in 2002 in the laboratory
of Pr Claude Jacq (ENS, Paris, France). In 2008, he got a full professor position in microbial
genomics at UPMC and he created his research team at the laboratory of computational
and quantitative biology, studying transcriptional and post-transcriptional stress regulatory
networks in various yeast species.
PROGRAM | 8
Marie-Claude PotierDirector of Research
PhD, Pharm. D., Director of Research at CNRS
ICM - Brain & Spine Institute
Paris – France
Dr. Marie-Claude Potier is Director of Research at the French National Center for Scientific
Research (CNRS) and Co-Group Leader of the “Alzheimer’s and Prion Diseases” research
group at ICM-Institut du Cerveau et de la Moelle Epinière (Brain and Spine Institute), at the
Pitié-Salpêtrière Hospital, Paris, France.
Dr. Marie-Claude Potier and her team investigate the role of lipids, particularly cholesterol
and alipoprotein E in the secretion and neuronal transport, their involvement in endosomal
modifications that occur early during the course of the disease and novel mechanisms of
AB toxicity identified in vivo. She initiated translational research programs with on-site
clinicians and developed a microfluidic platform for studying the transcription of single
cells and producing microfluidic devices for neuronal cultures.
After a PharmD in Neuropharmacology at the University Réné Descartes, Paris, France and
a PhD at the University Pierre and Marie Curie, Paris, France, she was trained in molecular
and cellular biology during three years post-doct at the MRC Laboratory of Molecular
Biology, Cambridge, UK. She returned to the Alfred Fessard Institute when she obtained a
permanent scientific staff position at CNRS and later joined the School of Physic &
Chemistry (ESPCI), Paris France. She lately joined the ICM in 2008.
Dr. Marie-Claude Potier has been working for the past twenty-five years on Down
syndrome (DS) and is now developing pharmacological treatments for increasing
cognition in DS.
Dr. Marie-Claude Potier published more than one hundred papers in scientific journals and
is since 2017 Corresponding Member of the French Academy of Medicine. She received the
Dagnan-Bouveret Prize from The French Science Academy in 2005.
SCIENTIFIC ORGANIZING COMMITTEE
PROGRAM | 9
Stéphane Le CromProfessor of genomics
Sorbonne Université, IBPS – Institut de Biologie Paris Seine
Paris – France
Stéphane Le Crom is a Professor of Genomics at Sorbonne Université (ex Pierre et Marie
Curie, Paris, France). He got a Ph.D. in Cellular Neurobiology in 2000 at Paris-Sud Orsay
University. He performed two post-doctoral internships: one on yeast transcriptomics
(Claude Jacq’s team, Paris) and the other on protein-protein interaction analysis (Stephen
Michnick laboratory, Montréal). He has been recruited as an assistant professor in 2003 to
join the group of Patrick Charnay at École normale supérieure on genomic aspects of
development of the vertebrate nervous system.
Since 2007, he is the scientific director of the Genomics core facility at École normale
supérieure Biology Institute (IBENS in Paris. This facility has been created in 1999 for
providing access to functional genomics technologies with the main objectives to help
laboratories managing their genomic projects, disseminate genome-wide approaches
among the scientific community, and develop competence and diversified resources in
bioinformatics analyses of functional genomic data.
Since 2014 he is responsible for the Sorbonne Université Omics network that gathers 21
structures involved in data production in genomics (microarrays, high throughput
sequencing and qPCR), molecular analysis (proteomics, mass spectrometry, lipidomics and
metabolomics), biological resources’ management and associated bioinformatics.
SCIENTIFIC ORGANIZING COMMITTEE
PROGRAM | 10
MUSÉE D’ORSAY PRIVATE VISIT
PROGRAM | 11
19h – 20h30
Located in the heart of Paris, along the Seine river, in front of the Tuileries garden, the
Musée d’Orsay is the former Orsay railway station built in 1900 for the world exhibition. In
one of the historical place in Paris, the museum and its restaurant are awesome references
to French culture.
ANNIVERSARY GALA DINNER
20h30
The former restaurant of the Hôtel d’Orsay, on the first floor of the museum, is still as
magnificent as it was when it opened in 1900. The new furniture sets off the dazzling
chandeliers and the painted and gilded ceilings of this dining room, listed as a Historic
Monument. The chef Yann Landureau offers traditional French cuisine, interspersed with
original dishes that are linked to the museum’ current events.
INSTITUTIONAL PARTNERS
PROGRAM | 12
SPONSORS
GOLD
SILVER
BRONZE